Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
3.830
+0.050 (1.32%)
At close: Jul 24, 2026, 4:00 PM EDT
3.794
-0.036 (-0.94%)
After-hours: Jul 24, 2026, 7:57 PM EDT
Plus Therapeutics Employees
Plus Therapeutics had 28 employees as of December 31, 2025. The number of employees increased by 7 or 33.33% compared to the previous year.
Employees
28
Change (1Y)
7
Growth (1Y)
33.33%
Revenue / Employee
$185,071
Profits / Employee
-$426,107
Market Cap
26.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | 7 | 33.33% |
| Dec 31, 2024 | 21 | 1 | 5.00% |
| Dec 31, 2023 | 20 | 3 | 17.65% |
| Dec 31, 2022 | 17 | 3 | 21.43% |
| Dec 31, 2021 | 14 | 2 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| Kyntra Bio | 34 |
| Actinium Pharmaceuticals | 25 |
| ABVC BioPharma | 19 |
| Barinthus Biotherapeutics | 14 |
| Tvardi Therapeutics | 12 |
PSTV News
- 5 days ago - Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer - GlobeNewsWire
- 10 days ago - Plus Therapeutics, Genomic Testing Cooperative partner on sequencing technology - TheFly
- 10 days ago - Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform - GlobeNewsWire
- 12 days ago - Plus Therapeutics reports NCCN Central Nervous System Cancers guidelines update - TheFly
- 12 days ago - Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring - GlobeNewsWire
- 26 days ago - Plus Therapeutics Transcript: Investor update - Transcripts
- 26 days ago - Plus Therapeutics Press release: Investor update - Filings
- 26 days ago - Plus Therapeutics to change name, ticker symbol - TheFly